We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Solvo Biotechnology Appoints Yuichi Sugiyama to the Scientific Advisory Board

News   Jul 23, 2007

 
Solvo Biotechnology Appoints Yuichi Sugiyama to the Scientific Advisory Board
 
 
Advertisement
 

RELATED ARTICLES

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new study.

READ MORE

Team Develops Synthetic Blood-Thinner With No Bleeding Side Effects

News

Scientists have developed a highly selective and highly stable synthetic blood-thinning molecule that, unlike others, doesn’t cause bleeding adverse effects.

READ MORE

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE